Who are Ventaris Surgical's investors?

Ventaris Surgical's investors include Boutique Venture Partners, Longitude Capital, Neotribe Ventures, SCP Ventures, LLC, Vensana Capital.

How much funding has Ventaris Surgical raised?

Ventaris Surgical has disclosed $30.7M raised across 1 round.

Where is Ventaris Surgical headquartered?

Ventaris Surgical is headquartered in San Carlos, US.

Ventaris Surgical

San Carlos, US · Founded 2024 · Delaware corporation · 5 known investors

Find your way into Ventaris Surgical

Paths you didn't know you had: your email and LinkedIn already hold routes to the Ventaris Surgical team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ventaris Surgical develops investigational medical devices that are currently under development and have not yet received FDA or other regulatory approval for commercial use.

Biotech Healthtech Medical Devices

Founders & leadership

Surag MantriExecutive

Board

Justin Klein Board directorCo-Founder and Managing Partner at Vensana Capital

Matthew SprinkelBoard director

Amir AbolfathiBoard director

Varun Gupta Board Member2026–2026Principal at Longitude Capital

Investors · 5

Boutique Venture Partnerslisted by Boutique Venture PartnersPalo Alto

Longitude Capitallisted by Longitude CapitalMenlo Park · $10M – $30M

How we know: Longitude Capital's portfolio page · a partner's Signal profile · funding news · Not right? Tell us

Neotribe Ventureslisted by Neotribe VenturesMenlo Park · $250K – $2M

How we know: Neotribe Ventures's portfolio page · Not right? Tell us

SCP Ventures, LLClisted by SCP Ventures, LLC

Vensana CapitalreportedMinneapolisvia Justin Klein · board

How we know: a partner's Signal profile · board seat on SEC Form D · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$30.7M disclosed across 1 round · 2026

▶$30.7MraisedMar 2026 · 57 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Matthew SprinkelDirector
Justin KleinDirector
Surag MantriExecutive Officer, Director
Amir AbolfathiDirector
Varun GuptaDirector

Offering amount: $30.7M
Amount sold: $30.7M
First sale: Jan 2026
Incorporated: Corporation, Delaware, 2024
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Sparta BiomedicalSparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.

Companies working in the same space as Ventaris Surgical.

In the news

Ventaris Surgical Raises $30M in Series A Fundingfinsmes.com · Jan 2026

Ventaris Surgical, Inc. Announces $30M Series A to Advance a Next-Generation System for Complete Kidney Stone Treatmentprnewswire.com · Jan 2026

Frequently asked questions

What does Ventaris Surgical do?: Ventaris Surgical develops investigational medical devices that are currently under development and have not yet received FDA or other regulatory approval for commercial use.
Who are Ventaris Surgical's investors?: Ventaris Surgical's investors include Boutique Venture Partners, Longitude Capital, Neotribe Ventures, SCP Ventures, LLC, Vensana Capital.
How much funding has Ventaris Surgical raised?: Ventaris Surgical has disclosed $30.7M raised across 1 round.
Where is Ventaris Surgical headquartered?: Ventaris Surgical is headquartered in San Carlos, US.